Yahoo Web Search

Search results

    • Novavax Reports First Quarter 2024 Financial Results and Operational Highlights

      NBC 17 Raleigh· 10 hours ago

      ...combination product near-term milestones, plus ongoing tiered royalties on product salesUp to $200 million in milestones plus royalties for each new vaccine developed utilizing Novavax's Matrix-MTM adjuvantAnnounces addition of standalone influenza vaccine to Phase 3 COVID-19-Influenza...

    • Novavax gets a lifeline with Sanofi vaccine pact

      Novavax gets a lifeline with Sanofi vaccine pact

      BioPharma Dive via Yahoo Finance· 6 hours ago

      Sanofi will ally with the under-pressure biotech, paying $500 million upfront for rights to co-commercialize Novavax’s COVID shot and develop combination...